At Curigin, we are developing innovative therapies using our novel bi-specific shRNA technology to simultaneously knockdown two different disease causing pathways.
Our lead pipelines target cancer pathways such as mTOR and STAT3 and deliver our bi-specific shRNA through an oncolytic virus genetically engineered to exclusively target and replicate in cancer cells.
Company Details
- Employees
- 9
- Address
- Seoul Forest M Tower, Seoul,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.curigin.co.kr/
- Keywords
- 성남시.
- HQ
- Seoul
Curigin Inc. Questions
Curigin Inc.'s website is http://www.curigin.co.kr/
Curigin Inc.'s LinkedIn profile is https://kr.linkedin.com/company/curigin-inc
Curigin Inc. has
9 employees.
View email and phone details for 9
employees at Curigin Inc..
Curigin Inc.'s industry is
Biotechnology Research
Curigin Inc.'s top competitors are
Topalliance Biosciences Inc,
Mitoimmune Therapeutics Inc.,
Epithelix,
Imquest Biosciences,
Ibt Bioservices,
Geninus Inc.,
Mcurex Therapeutics, Inc.,
Rznomics Inc.,
Stgen Bio,
Xylonix.io.
Curigin Inc.'s categories are Biotechnology Research
